Developer docs
API playgroundTry for free, no card

Search company profiles

Shaily Engineering Plastics

Full company profile

uuid0005arr

Namestring
Shaily Engineering Plastics
Legal namestring
Shaily Engineering Plastics Ltd.
Websiteurl
shaily.com
Company typeenum
Public
Founded yearint
1987
Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
501–1,000
akta.pro rankint
HeadquartersVadodara, India
HQ citystring
Vadodara
HQ countrystring
India
HQ regionstring
Asia
Markets served

Serves global market

Offices9 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
precision injection molding, drug delivery devices, contract manufacturing services, pen injector platforms, plastic component manufacturing
Industry2 codes
1High-Performance & Engineering Polymers Injection Molding (PEEK, PPS, LCP, etc.)
CodeIMANAFAKPrimaryYes
2Automotive & Transportation Injection Molded Parts
CodeIMANAFABPrimaryNo
NAICS code2 codes
  • Plastics Product Manufacturing3261
  • Plastics and Rubber Products Manufacturing326
SIC code1 code
  • Miscellaneous Plastics Products3080
Product category
Precision Plastic Contract Manufacturing
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model3 records
1Contract Manufacturing - Healthcare
TypeOne Time License
Description

CDMO services for pharmaceutical companies including design, development, and manufacturing of drug delivery devices (pen injectors, auto-injectors) and primary packaging. Revenue from long-term supply agreements with pharma companies. Healthcare segment grew 139% to ₹393 crores in FY26.

financialexpress.com
2Contract Manufacturing - Consumer & Industrial
TypeHardware Sales
Description

Precision plastic components manufacturing for consumer goods, beauty/personal care, lighting, appliances, and automotive sectors. Serves Fortune 100 companies including IKEA, P&G, HUL with components for homeware, cosmetics packaging, and industrial applications.

shaily.com
3Sheet Steel Furniture
TypeHardware Sales
Description

Sheet metal furniture manufacturing with 70,000 sq ft plant processing 6,000 tons of steel per annum, producing cabinets, drawer units, tables and storage units for global customers.

financialexpress.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Pricing details1 tier
1Custom manufacturing agreements for pharmaceutical companies
ModelOtherBilling cadenceMulti-year contract
Notes

Pen injector supply agreement worth ₹423 crore over four years from domestic pharmaceutical company. Pricing determined through individual contract negotiations based on volume, complexity, and specifications.

business-standard.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 5 records shown
1ShailyPen
Description

Platform of pen injectors including ShailyPen Axiom, ShailyPen Protean, ShailyPen Neo, ShailyPen Axiom Max, ShailyPen Harmony 2, and ShailyPen Maxim for insulin and GLP-1 drug delivery.

shaily.com
+4 more records
Core offering1 text field

Shaily Engineering Plastics is a precision plastic components manufacturer and CDMO offering end-to-end solutions from concept to commercialization. The company operates 210 injection molding machines (35-1200 tons) across seven manufacturing plants, producing proprietary pen injector and auto-injector drug delivery platforms (ShailyPen, Shaily AI), primary pharmaceutical packaging, and precision plastic components for consumer goods, beauty/personal care, lighting, appliances, and automotive sectors.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • Return on Capital Employed (ROCE) of 29%, significantly outperforming Machinery industry average of 15%
+4 more records
Product overview1 text field

Shaily Engineering Plastics is a precision plastic components manufacturer offering a diversified portfolio across four main verticals: Healthcare (drug delivery devices and primary packaging), Consumer products (homeware and sheet steel furniture), Beauty and Personal Care (cosmetics packaging and personal care products), and Lighting, Appliances and Automotive. Within Healthcare, the company operates as both a CDMO for global pharmaceutical companies and a platform devices provider with its proprietary pen injector and auto-injector product lines (ShailyPen and Shaily AI series), plus primary and specialty pharmaceutical packaging. The product architecture follows a platform-plus-modules model where core device platforms (pen injectors, auto-injectors, wearable devices) are customized for specific drug therapies and delivered as both contract manufacturing services and proprietary platforms.

Product and service14 records
1ShailyPen Axiom
CategoryDrug Delivery Device
Description

Fixed-dose pen injector for teriparatide, PTH, and FSH therapies featuring a zero-prime design with red line indication when dose is selected and audible clicking during dose delivery.

2ShailyPen Protean
CategoryDrug Delivery Device
Description

Disposable or reusable pen injector for insulin (0-60 units), liraglutide, abaloparatide, and semaglutide; available in multiple configurations with high gearing and low force injection.

3ShailyPen Neo
CategoryDrug Delivery Device
Description

Variable or fixed-dose spring-driven pen injector for GLP-1, liraglutide, and semaglutide featuring a no-extension design, spring-driven mechanism, low consistent force, and ergonomic use with approximately 4 seconds delivery time at max dose.

4ShailyPen Axiom Max
CategoryDrug Delivery Device
Description

GLP-1 pen injector with large dose volume (0.75 ml customizable), zero prime, and low force extension; features dose counter and instruction window for simple user steps.

5ShailyPen Harmony 2
CategoryDrug Delivery Device
Description

Pen injector available in 3 ml (0.75 ml dose) and 1.5 ml (0.375 ml or 0.1875 ml doses) configurations with low dial extension, dose markings, and audible clicking feedback.

6ShailyPen Maxim
CategoryDrug Delivery Device
Description

80-unit reusable or disposable pen injector for insulin, GLP-1, and alternate therapies with low extension design, high dose volumes (0.8 ml), and optional resettable functionality.

7Shaily AI Tristan
CategoryDrug Delivery Device
Description

Three-step auto-injector for tirzepatide, dulaglutide, and GLP-1 with automated needle extension and retraction, button lock-out after dosing, approximately 2 second delivery time, and ISO 11040/11608 compliance.

8Shaily AI Toby
CategoryDrug Delivery Device
Description

Two-step auto-injector for GLP-1 and epinephrine available in 1 ml, 2.25 ml, and emergency use configurations with needle cover lock-out after dosing.

9Shaily Mira
CategoryDrug Delivery Device
Description

Wearable auto-injector for various therapies with electronic button actuation, up to 20 ml dose capacity, customizable delivery time (1 minute to 2 hours), and play/pause injection control with LED feedback.

10ShailySafe LAN
CategoryDrug Delivery Device
Description

Safety device for lanreotide with automated needle retraction, device lockout after dosing, suitability for high-viscosity medications, and 20 second delivery time.

11Primary & Specialty Pharmaceutical Packaging
CategoryPharmaceutical Packaging
Description

High quality packaging for solid orals and liquid formulations including bottles and child-resistant closures (CRCs); specialized packaging for therapies where primary pack aids in delivery; backed by US DMF and Canadian DMF filings.

12CDMO Drug Delivery Contract Manufacturing
CategoryContract Manufacturing Services
Description

Contract development and manufacturing organization (CDMO) services for global pharmaceutical companies including design, development, and manufacturing of specialty devices, inhalers, sprays, pumps, insulin injector pens, and auto-injectors.

13Injection Molding & Precision Manufacturing Services
CategoryContract Manufacturing Services
Description

Precision injection molding services with 210 machines ranging from 35 to 1200 tons; capable of manufacturing components as small as 0.03 grams with 5 micron tolerances; includes mold manufacturing, secondary operations, and assembly services.

14Sheet Steel Furniture Manufacturing
CategorySteel Furniture Manufacturing
Description

Sheet metal furniture manufacturing producing cabinets, drawer units, tables and storage units for global customers from a 70,000 sq ft plant processing 6,000 tons of steel per annum.

Scale indicator17 records

Each record includes

Type, Value, Description, Source

Partnership2 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-05-21
Description

Strategic partnership where Orbicular Pharmaceutical Technologies, in partnership with their customer, launched a generic semaglutide injection in Canada using Shaily's proprietary ShailyPen Neo spring-driven pen injector platform. The combination product received USFDA Tentative Approval, Health Canada Notice of Compliance, and India CDSCO approval, and has been commercially available in India since March 2026.

2Undisclosed Domestic Pharmaceutical Company
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-02-26
Description

Manufacturing and commercial supply agreement worth approximately ₹423 crore over four years for pen injectors. Customer name not disclosed due to confidentiality. Contract does not involve related party transactions.

business-standard.com
Recent move3 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

French drug delivery device manufacturer producing pen injectors, auto-injectors, inhalers, and patch injectors. Competes with Shaily's ShailyPen Neo and Shaily AI platforms for pharma OEM contracts across injectable therapies.

TypeBroad incumbent
Description

German-headquartered manufacturer of primary pharmaceutical packaging (glass and plastic containers, prefillable syringes) and drug delivery devices. Larger European incumbent with overlapping pharma packaging and device CDMO operations.

TypeDirect peer
Description

Italian-based manufacturer of drug containment solutions, pre-filled syringes, and drug delivery devices including pen injectors. Operates a CDMO model serving global pharma - directly comparable to Shaily's healthcare CDMO and platform device business with primary packaging overlap.

TypeRegional player
Description

India-listed global leader in laminated and plastic tubes for oral care, beauty, and pharma applications. Comparable precision plastics manufacturer headquartered in India serving consumer goods and pharma customers - similar multi-vertical injection-molded plastics business model.

TypeBroad incumbent
Description

US-listed medical technology giant with a substantial pharmaceutical systems segment producing pre-filled syringes, auto-injectors, and pen injectors. Significantly larger and broader, but directly competes in the same pharma drug-delivery device CDMO space.

TypeRegional player
Description

India-listed manufacturer of polyester (PET) films used in packaging and industrial applications. Comparable Indian-listed precision plastics manufacturer with global export footprint; an independent director (Ranjit Singh) of Shaily previously served as Global COO of Polyplex.

TypeBroad incumbent
Description

US-listed global supplier of dispensing systems, drug delivery devices, and active material science solutions for pharma, beauty, and consumer markets. Comparable to Shaily's combined pharma drug delivery plus beauty/personal care packaging businesses.

TypeBroad incumbent
Description

US-listed global leader in pharmaceutical elastomers, primary packaging, and drug delivery devices including the SmartDose and Daikyo Crystal Zenith platforms. Larger incumbent serving overlapping pharma customers; broader portfolio but comparable drug-delivery component technology.

TypeDirect peer
Description

UK-based designer and manufacturer of drug delivery devices including pen injectors (AutoPen, UniSafe) and auto-injectors for diabetes and other therapies. Closely comparable to Shaily's pen injector platforms and serves similar global pharma CDMO customers.

TypeDirect peer
Description

Swiss-headquartered leader in pen injectors and auto-injectors for insulin, GLP-1, and other injectable therapies. Directly comparable to Shaily's ShailyPen/Shaily AI platform devices serving global pharma customers with proprietary drug-delivery platforms.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers19 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Subsidiaries3 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance16 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds4 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors4 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Shaily Engineering Plastics

Precision Plastic Contract Manufacturingshaily.com

Shaily Engineering Plastics firmographics

Firmographics
Name
Shaily Engineering Plastics
Legal name
Shaily Engineering Plastics Ltd.
Website
https://shaily.com
Company type
Public
Founded year
1987
Operating status
Operating
Headcount range
501–1,000 employees
Ownership category
akta.pro rank

Shaily Engineering Plastics industry classification

Industry
Product category
Precision Plastic Contract Manufacturing
NAICS
Plastics Product Manufacturing (3261), Plastics and Rubber Products Manufacturing (326)
SIC
Miscellaneous Plastics Products (3080)
akta.pro primary industry
High-Performance & Engineering Polymers Injection Molding (PEEK, PPS, LCP, etc.) (IMANAFAK)
akta.pro secondary industry
Automotive & Transportation Injection Molded Parts (IMANAFAB)

Keywords

  • Precision injection molding
  • Drug delivery devices
  • Contract manufacturing services
  • Pen injector platforms
  • Plastic component manufacturing

Where Shaily Engineering Plastics is headquartered

Location

Headquarters

HQ city
Vadodara
HQ country
India
HQ region
Asia

Offices9 records

Markets served

Shaily Engineering Plastics business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing

Revenue model

  1. Contract Manufacturing - Healthcare: CDMO services for pharmaceutical companies including design, development, and manufacturing of drug delivery devices (pen injectors, auto-injectors) and primary packaging. Revenue from long-term supply agreements with pharma companies. Healthcare segment grew 139% to ₹393 crores in FY26.
  2. Contract Manufacturing - Consumer & Industrial: Precision plastic components manufacturing for consumer goods, beauty/personal care, lighting, appliances, and automotive sectors. Serves Fortune 100 companies including IKEA, P&G, HUL with components for homeware, cosmetics packaging, and industrial applications.
  3. Sheet Steel Furniture: Sheet metal furniture manufacturing with 70,000 sq ft plant processing 6,000 tons of steel per annum, producing cabinets, drawer units, tables and storage units for global customers.

Pricing tiers

ModelBillingPrice
OtherMulti-year contractCustom manufacturing agreements for pharmaceutical companies

Go-to-market motion2 records

Distribution channels3 records

Marketing channels4 records

Shaily Engineering Plastics product offering

Product offering

Core offering

Shaily Engineering Plastics is a precision plastic components manufacturer and CDMO offering end-to-end solutions from concept to commercialization. The company operates 210 injection molding machines (35-1200 tons) across seven manufacturing plants, producing proprietary pen injector and auto-injector drug delivery platforms (ShailyPen, Shaily AI), primary pharmaceutical packaging, and precision plastic components for consumer goods, beauty/personal care, lighting, appliances, and automotive sectors.

Product overview

Shaily Engineering Plastics is a precision plastic components manufacturer offering a diversified portfolio across four main verticals: Healthcare (drug delivery devices and primary packaging), Consumer products (homeware and sheet steel furniture), Beauty and Personal Care (cosmetics packaging and personal care products), and Lighting, Appliances and Automotive. Within Healthcare, the company operates as both a CDMO for global pharmaceutical companies and a platform devices provider with its proprietary pen injector and auto-injector product lines (ShailyPen and Shaily AI series), plus primary and specialty pharmaceutical packaging. The product architecture follows a platform-plus-modules model where core device platforms (pen injectors, auto-injectors, wearable devices) are customized for specific drug therapies and delivered as both contract manufacturing services and proprietary platforms.

Differentiator

Problem solved

Functional benefit

Brands

  • ShailyPen: Platform of pen injectors including ShailyPen Axiom, ShailyPen Protean, ShailyPen Neo, ShailyPen Axiom Max, ShailyPen Harmony 2, and ShailyPen Maxim for insulin and GLP-1 drug delivery.
  • Shaily AI
  • Shaily Mira
  • ShailySafe LAN
  • Shaily Innovations

Products and services

  • ShailyPen Axiom Fixed-dose pen injector for teriparatide, PTH, and FSH therapies featuring a zero-prime design with red line indication when dose is selected and audible clicking during dose delivery.
  • ShailyPen Protean Disposable or reusable pen injector for insulin (0-60 units), liraglutide, abaloparatide, and semaglutide; available in multiple configurations with high gearing and low force injection.
  • ShailyPen Neo Variable or fixed-dose spring-driven pen injector for GLP-1, liraglutide, and semaglutide featuring a no-extension design, spring-driven mechanism, low consistent force, and ergonomic use with approximately 4 seconds delivery time at max dose.
  • ShailyPen Axiom Max GLP-1 pen injector with large dose volume (0.75 ml customizable), zero prime, and low force extension; features dose counter and instruction window for simple user steps.
  • ShailyPen Harmony 2 Pen injector available in 3 ml (0.75 ml dose) and 1.5 ml (0.375 ml or 0.1875 ml doses) configurations with low dial extension, dose markings, and audible clicking feedback.
  • ShailyPen Maxim 80-unit reusable or disposable pen injector for insulin, GLP-1, and alternate therapies with low extension design, high dose volumes (0.8 ml), and optional resettable functionality.
  • Shaily AI Tristan Three-step auto-injector for tirzepatide, dulaglutide, and GLP-1 with automated needle extension and retraction, button lock-out after dosing, approximately 2 second delivery time, and ISO 11040/11608 compliance.
  • Shaily AI Toby Two-step auto-injector for GLP-1 and epinephrine available in 1 ml, 2.25 ml, and emergency use configurations with needle cover lock-out after dosing.
  • Shaily Mira Wearable auto-injector for various therapies with electronic button actuation, up to 20 ml dose capacity, customizable delivery time (1 minute to 2 hours), and play/pause injection control with LED feedback.
  • ShailySafe LAN Safety device for lanreotide with automated needle retraction, device lockout after dosing, suitability for high-viscosity medications, and 20 second delivery time.
  • Primary & Specialty Pharmaceutical Packaging High quality packaging for solid orals and liquid formulations including bottles and child-resistant closures (CRCs); specialized packaging for therapies where primary pack aids in delivery; backed by US DMF and Canadian DMF filings.
  • CDMO Drug Delivery Contract Manufacturing Contract development and manufacturing organization (CDMO) services for global pharmaceutical companies including design, development, and manufacturing of specialty devices, inhalers, sprays, pumps, insulin injector pens, and auto-injectors.
  • Injection Molding & Precision Manufacturing Services Precision injection molding services with 210 machines ranging from 35 to 1200 tons; capable of manufacturing components as small as 0.03 grams with 5 micron tolerances; includes mold manufacturing, secondary operations, and assembly services.
  • Sheet Steel Furniture Manufacturing Sheet metal furniture manufacturing producing cabinets, drawer units, tables and storage units for global customers from a 70,000 sq ft plant processing 6,000 tons of steel per annum.

Quantifiable outcome

  • Return on Capital Employed (ROCE) of 29%, significantly outperforming Machinery industry average of 15%
  • +4 more outcomes

Companies that use Shaily Engineering Plastics

Customer profile

Named customers19 records

Segments4 records

Shaily Engineering Plastics technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

Shaily Engineering Plastics partnerships and signals

Strategic signal

Partnerships

Two partnerships are on record, tiered core.

  • Orbicular Pharmaceutical TechnologiescoreStrategic or Co-development Partner · 21 May 2026Strategic partnership where Orbicular Pharmaceutical Technologies, in partnership with their customer, launched a generic semaglutide injection in Canada using Shaily's proprietary ShailyPen Neo spring-driven pen injector platform. The combination product received USFDA Tentative Approval, Health Canada Notice of Compliance, and India CDSCO approval, and has been commercially available in India since March 2026.
  • Undisclosed Domestic Pharmaceutical CompanycoreStrategic or Co-development Partner · 26 February 2026Manufacturing and commercial supply agreement worth approximately ₹423 crore over four years for pen injectors. Customer name not disclosed due to confidentiality. Contract does not involve related party transactions.

Scale indicators17 records

Recent moves3 records

Expansion highlights5 records

Shaily Engineering Plastics competitors and assessment

Company assessment

Direct peers

  • Nemera: French drug delivery device manufacturer producing pen injectors, auto-injectors, inhalers, and patch injectors. Competes with Shaily's ShailyPen Neo and Shaily AI platforms for pharma OEM contracts across injectable therapies.
  • Stevanato Group: Italian-based manufacturer of drug containment solutions, pre-filled syringes, and drug delivery devices including pen injectors. Operates a CDMO model serving global pharma - directly comparable to Shaily's healthcare CDMO and platform device business with primary packaging overlap.
  • Owen Mumford: UK-based designer and manufacturer of drug delivery devices including pen injectors (AutoPen, UniSafe) and auto-injectors for diabetes and other therapies. Closely comparable to Shaily's pen injector platforms and serves similar global pharma CDMO customers.
  • Ypsomed Holding AG: Swiss-headquartered leader in pen injectors and auto-injectors for insulin, GLP-1, and other injectable therapies. Directly comparable to Shaily's ShailyPen/Shaily AI platform devices serving global pharma customers with proprietary drug-delivery platforms.

Broad incumbents

  • Gerresheimer AG: German-headquartered manufacturer of primary pharmaceutical packaging (glass and plastic containers, prefillable syringes) and drug delivery devices. Larger European incumbent with overlapping pharma packaging and device CDMO operations.
  • Becton Dickinson (BD): US-listed medical technology giant with a substantial pharmaceutical systems segment producing pre-filled syringes, auto-injectors, and pen injectors. Significantly larger and broader, but directly competes in the same pharma drug-delivery device CDMO space.
  • AptarGroup: US-listed global supplier of dispensing systems, drug delivery devices, and active material science solutions for pharma, beauty, and consumer markets. Comparable to Shaily's combined pharma drug delivery plus beauty/personal care packaging businesses.
  • West Pharmaceutical Services: US-listed global leader in pharmaceutical elastomers, primary packaging, and drug delivery devices including the SmartDose and Daikyo Crystal Zenith platforms. Larger incumbent serving overlapping pharma customers; broader portfolio but comparable drug-delivery component technology.

Regional players

  • EPL Limited (formerly Essel Propack): India-listed global leader in laminated and plastic tubes for oral care, beauty, and pharma applications. Comparable precision plastics manufacturer headquartered in India serving consumer goods and pharma customers - similar multi-vertical injection-molded plastics business model.
  • Polyplex Corporation Limited: India-listed manufacturer of polyester (PET) films used in packaging and industrial applications. Comparable Indian-listed precision plastics manufacturer with global export footprint; an independent director (Ranjit Singh) of Shaily previously served as Global COO of Polyplex.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Shaily Engineering Plastics social profiles

Digital presence

Shaily Engineering Plastics compliance and trust

Trust signal

Compliance16 records

Shaily Engineering Plastics financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Shaily Engineering Plastics leadership team

Management profile

Number of profiles

Shaily Engineering Plastics subsidiaries and ownership

Company hierarchy

Subsidiaries3 records

Shaily Engineering Plastics funding detail

Funding detail

Funding overview

Funding rounds4 records

Investors4 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Shaily Engineering Plastics M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Shaily Engineering Plastics

What does Shaily Engineering Plastics do?

Shaily Engineering Plastics is a precision plastic components manufacturer and CDMO offering end-to-end solutions from concept to commercialization. The company operates 210 injection molding machines (35-1200 tons) across seven manufacturing plants, producing proprietary pen injector and auto-injector drug delivery platforms (ShailyPen, Shaily AI), primary pharmaceutical packaging, and precision plastic components for consumer goods, beauty/personal care, lighting, appliances, and automotive sectors.

Is Shaily Engineering Plastics a public or private company?

Shaily Engineering Plastics is a public company. It is classified as public and is currently operating.

When was Shaily Engineering Plastics founded?

Shaily Engineering Plastics was founded in 1987. It employs 501 to 1,000 people.

Where is Shaily Engineering Plastics based?

Shaily Engineering Plastics is headquartered in Vadodara, India, in the Asia region.

How does Shaily Engineering Plastics make money?

Three revenue lines are on record. Contract Manufacturing - Healthcare is the primary driver. The others are contract Manufacturing - Consumer & Industrial and sheet Steel Furniture.

Who are Shaily Engineering Plastics's main competitors?

Direct peers on record are Nemera, Stevanato Group, Owen Mumford and Ypsomed Holding AG. Broad incumbents are Gerresheimer AG, Becton Dickinson (BD), AptarGroup and West Pharmaceutical Services. Regional players are EPL Limited (formerly Essel Propack) and Polyplex Corporation Limited.

Does Shaily Engineering Plastics have an API?

No public API is recorded for Shaily Engineering Plastics.

What industry is Shaily Engineering Plastics in?

Shaily Engineering Plastics's product category is Precision Plastic Contract Manufacturing. Its primary akta.pro industry code is IMANAFAK, High-Performance & Engineering Polymers Injection Molding (PEEK, PPS, LCP, etc.), with a secondary code of IMANAFAB, Automotive & Transportation Injection Molded Parts. Its NAICS code is 3261 and its SIC code is 3080.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Simply Wall StShaily Engineering Plastics And 2 Indian Growth Stocks To WatchShaily Engineering Plastics, Timex Group India, and Cemindia Projects are highlighted as Indian growth stocks, with revenue and market cap figures provided. Shaily generates ₹10.25b revenue, Timex ₹8.49b, and Cemindia ₹102.05b, with market values of ₹140.91b, ₹73.22b, and ₹193.50b respectively. The article notes regulatory delays and funding cost pressures as potential headwinds.YahooOur Pick Of The Best Indian Growth Stocks In October 2026Three Indian growth stocks—Shaily Engineering Plastics, Timex Group India, and Cemindia Projects—are highlighted for their expansion potential. Shaily's pharma devices and CDMO services, Timex's watch earnings up 117% last year, and Cemindia's large infrastructure order book are cited. Analysts note regulatory and funding pressures could temper growth.Simply Wall StShaily Engineering Plastics And 2 Other Indian Growth StocksShaily Engineering Plastics, Sky Gold and Diamonds, and Cemindia Projects are profiled as Indian growth stocks with solid financials. Shaily's pharma device CDMO revenue is about ₹10,246 million, Sky Gold's gold jewellery revenue is ₹71.8 billion, and Cemindia's construction revenue is ₹102.1 billion. The article notes regulatory delays and contract economics as key risks.ScanXShaily Engineering Plastics submits final annual report for FY26Shaily Engineering Plastics submitted its final FY26 annual report to BSE and NSE on September 9, 2026, correcting photographs on pages 2 and 3 from an earlier September 4 filing. The submission complies with Regulation 34 of SEBI Listing Obligations Regulations, and the company's registered office is in Vadodara.ScanXShaily Engineering Plastics schedules 46th AGM for September 28Shaily Engineering Plastics will hold its 46th AGM on September 28, 2026, via video conferencing, with remote e-voting open from September 25 to 27. Shareholders must update PAN details by September 11 for dividend TDS compliance. The meeting will address financial statements, a proposed ₹3 dividend, and a ₹500 crore capital raise.Simply Wall St3 Indian Growth Stocks To Own In September 2026Three Indian growth stocks—Monolithisch India, Shaily Engineering Plastics, and Schneider Electric Infrastructure—are profiled for September 2026, with revenue and market cap figures. Analysts expect strong earnings growth, but the stocks trade on rich valuations and face margin or capacity risks.ScanXShaily Engineering Plastics files FY26 BRSR reportShaily Engineering Plastics filed its FY26 BRSR on September 4, 2026, reporting standalone turnover of ₹921.19 crore and net worth of ₹649.45 crore. Exports accounted for 67.7% of turnover, and total energy consumption rose to 132.5 million MJ. The company recorded zero fatalities and no lost-time injuries.Simply Wall St3 India Growth Stocks With Pricing Power Investors Should WatchThe article analyzes three Indian growth stocks—Shaily Engineering Plastics, Sky Gold and Diamonds, and Cemindia Projects—that possess pricing power amidst rising input costs. It highlights their respective market positions, financial metrics such as margins and debt levels, and the strategic risks associated with their expansion plans. The piece serves as a screening overview rather than reporting on specific new corporate events or transactions.YahooShaily Engineering Plastics Ltd (BOM:501423) (Q1 2027) Earnings Call Highlights: Healthcare ...Shaily Engineering Plastics reported strong Q1 FY27 financial results, with consolidated revenue rising 14% to INR 281 crores and PAT increasing 17% to INR 48 crores. The company's healthcare segment emerged as its largest contributor, surging 85% year-on-year to account for 51% of total revenue, driven by regulatory approvals for semaglutide injector supplies in Canada and Brazil.Business StandardShaily Engineering Plastics consolidated net profit rises 16.76% in the June 2026 quarterShaily Engineering Plastics reported a 16.76% increase in consolidated net profit to Rs 48.01 crore for the quarter ended June 2026, compared to Rs 41.12 crore in the same quarter of the previous year. Sales also grew 13.77% year-over-year to Rs 280.67 crore from Rs 246.69 crore, while operating profit margin improved to 29.59% from 27.69%. The financial data table shows corresponding improvements in PBDT (up 20%) and PBT (up 20%) for the period.